The association between obesity and type 2 diabetes has been found to be consistent across different ethnic populations. Our aim was to study the contribution of obesity to the development of type 2 diabetes in a non-obese Chinese population with a high prevalence of diabetes (9.8% in 1995 -1996). METHODS: Six-hundred and forty-four non-diabetic subjects were recruited from the Hong Kong Cardiovascular Risk Factor Prevalence Study (1995 -1996). This was a community-based population study which involved the use of a 75 g oral glucose tolerance test and 1985 World Health Organization diagnostic criteria. Their glycemic status was reassessed at 2 y. RESULTS: In subjects with impaired glucose tolerance (n ¼ 322), the annual progression rate to diabetes (4.8%; 95% CI 2.5 -7.1%), was 8-fold that in control subjects (0.6%; 95% CI 0.0 -1.4%; P < 0.001). Baseline waist -hip ratio (WHR; OR per unit increase ¼ 1.05; 95% CI 1.02 -1.07, P ¼ 0.0003) and post-load 2 h plasma glucose (OR per unit increase ¼ 2.02; 95% CI 1.76 -2.34, P < 0.0001) were significantly associated with glycemic status at 2 y in stepwise polytomous logistic regression analysis. Subjects with high baseline waist circumference or WHR ( ! median) were more likely to have worsening of glucose tolerance at 2 y than those with low waist circumference ( < median; conversion to diabetes, OR 3.8, P ¼ 0.001) or WHR ( < median; conversion to diabetes, OR 2.8, P ¼ 0.019). CONCLUSION: Abdominal obesity, readily assessed by the measurement of WHR or waist circumference, was for the first time shown prospectively to be independently associated with the deterioration of glucose tolerance in a Chinese population.
Introduction
The association between obesity and type 2 diabetes has been found to be consistent across different ethnic populations. The prevalence of obesity (when defined as a body mass index (BMI) > 30 kg=m 2 ) according to WHO criteria 1 among Chinese in different localities has been reported to be 6 -12%, 1 -4 and is considerably lower than that among Caucasians (15 -25%). 1, 5 However, the prevalence of type 2 diabetes mellitus reported among Chinese inhabitants in these communities (6 -12%) 4,6 -8 is comparable to that of Caucasians in the US and Europe. Failure of BMI to incorporate body fat distribution, an independent predictor of health risk, 9 might explain the apparent discrepancy. Impaired glucose tolerance (IGT) is widely accepted as a transitional state in the development of type 2 diabetes mellitus. 10 Although there have been a number of crosssectional studies in different Chinese populations 4, 7, 8, 11 reporting substantial variation in the prevalence of IGT, there have been only two prospective community-based studies, conducted in Northern China 12 and a Taiwanese island with a small population, 13 respectively, which examine the risk of progression to diabetes among Chinese subjects with IGT. The rate of progression from IGT to diabetes has been reported to be around 9.0 -11.0% per year. 12, 13 In order to study the contribution of obesity to the development of type 2 diabetes in a non-obese Chinese population with a high prevalence of diabetes (9.8% in 1995 -1996) , 4 we aimed to ascertain the conversion rate of IGT to type 2 diabetes, as compared to that in normal subjects, and the clinical and biochemical factors which predicted the deterioration in glucose tolerance in a fairly large cohort of Southern Chinese with equal representation of IGT and normal subjects in Hong Kong, a highly urbanized community.
Methods
This study was a follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study, 4 conducted from January 1995 to December 1996. This detailed study of 2900 Hong Kong Chinese aged 25 -74 y included a 75 g oral glucose tolerance test (OGTT). A major objective was to define the prevalence of type 2 diabetes and IGT, which was found to be 9.8 and 15%, respectively. The overall prevalence of obesity (when defined as BMI ! 30 kg=m 2 ) was 5.4% for men and 7.3% for women. 4 Four hundred and thirty-four subjects with IGT (defined as a fasting plasma glucose (FPG) < 7.8 mmol=l but a 2 h plasma glucose (PG) of 7.8 -< 11.1 mmol=l) were identified. Baseline demographic, anthropometric and biochemical data were collected. These subjects were invited to participate in a 2 y follow-up face-to-face interview and repeat OGTT was performed. Equal numbers of subjects with normal glucose tolerance (NGT; defined as both FPG and 2 h PG of < 7.8 mmol=l), matched for age and sex, were recruited from the same population source as controls. Diabetes was defined as FPG ! 7.8 mmol=l or 2h PG ! 11.1 mmol=l or both.
Height was measured to the nearest 0.5 cm and weight to the nearest 0.1 kg (DETECTO instrument, MO, USA). Participants were measured in socks, stockings or bare feet and light street clothing. BMI, calculated as weight=height, 2 was used as a measurement of general obesity. Waist and hip circumferences were measured twice to the nearest 0.5 cm and the means were used for subsequent analyses. Waist circumference was measured half way between the xiphisternum and the umbilicus while hip circumference was measured at the level of the greater trochanters.
14 Although waist circumference, as recommended by WHO, was measured midway between the lower rib margin and iliac crest, 15 this measurement and the one we adopted in this study was reported to be highly correlated (r > 0.95).
14 Waist -hip ratio (WHR) and waist circumference were used as indices of central obesity.
Two consecutive blood pressure measurements were taken on the right arm 2 -3 min apart with the subject seated for at least 10 min. Systolic and diastolic phase V pressures were recorded to the nearest 2 mmHg. Hypertensive subjects were defined as those on treatment with anti-hypertensive agents or those with untreated systolic BP ! 140 mmHg and=or diastolic BP ! 90 mmHg. 16 Fasting (12 h overnight) blood was taken for total cholesterol, triglyceride, HDL-cholesterol, which were measured on the Hitachi 747 analyzer as previously described. 17 Low density lipoprotein (LDL) cholesterol was calculated by the Friedewald's equation provided total triglycerides did not exceed 4.0 mmol=l. FPG and 2 h PG after a 75 g of oral glucose load were measured by the hexokinase method, using the standard reagent protocol, on a Hitachi 747 analyzer. Insulin was measured by Microparticle Enzyme Immunoassay (MEIA; Abbott Laboratories, Tokyo, Japan).
In addition, the homeostasis model assessment (HOMA) estimate of insulin resistance (HOMA IR), a simple assessment of insulin sensitivity, was calculated using the formula: FPG (mmol=l)Âfasting insulin (mU=ml)=22.5.
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Statistics Results are given as percentage or mean AE s.e.m. Unpaired ttest was used to compare group means. Differences between proportions were tested by the chi-square test. Logistic regression modeling was used to calculate odds ratios of glucose intolerance as dichotomous outcome variables. Glycemic status was analyzed as an ordinal dependent variable with three ranked categories, using stepwise polytomous logistic regression to select the significant predictors. The independent variables tested in the model included age, sex, smoking habit, blood pressure, lipid profile, fasting and 2 h glucose, HOMA IR and all three anthropometric variables (waist circumference, WHR and BMI). The odds ratio, per unit increase of a predictor, indicates the increase in the risk of moving from a lower category to the next higher category (ie from NGT to IGT, or from IGT to DM).
Variance inflation factors were calculated, and if they were below 10.0, inflation of estimated standard errors due to multicollinearity would be of no concern.
All analyzes were performed with SPSS and SAS. A probability less than 0.05 was considered statistically significant.
Results
Of the 434 IGT subjects identified at baseline, 322 (74.2%) completed the 2 y follow-up study. Attempts were made to contact age and sex matched NGT subjects by phone. Of the 525 subjects contacted, 322 (61.3%) agreed to participate and completed the 2 y follow-up protocol. The baseline characteristics of the subjects who returned for the study are detailed in Table 1 . The NGT and IGT subjects studied were well matched in terms of sex distribution and age. The IGT subjects as a group had significantly higher anthropometric measurements (BMI, WHR, waist circumference), blood pressure, total and LDL-cholesterol, fasting glucose, 2 h PG, fasting and 2 h insulin, and HOMA IR but lower HDLcholesterol level, (P < 0.001 vs NGT group, except for blood pressure and LDL-cholesterol, P < 0.01; Table 1 ).
Of the 322 IGT subjects, 31 (9.6%; 95% CI 6.4 -12.8%) progressed to diabetes, 117 (36.3%) remained as IGT, and 174 (54.0%) reverted to NGT. Of those in the NGT group, four (1.2%; 95% CI 2.8 -5.2%) progressed to diabetes, 32 (9.9%) were reclassified as having IGT, and 286 (88.8%) were still NGT. The annual rate of progression to diabetes in IGT (4.8%; 95% CI 2.5 -7.1%) was eight times that of NGT (0.6%; 95% CI 0.0% -1.4%; P < 0.001).
Central obesity and impaired glucose tolerance NMS Wat et al Table 2 summarizes the influence of baseline waist circumference and WHR on a number of dichotomous outcome measures of glucose tolerance at 2 y. Subjects with a waist circumference or WHR above or equal to the gender specific median had a significantly greater risk of conversion to diabetes at 2 y (Table 2) . Table 3 shows the results of stepwise polytomous logistic regression modeling with glycemic status at 2 y as an ordinal variable (the non-significant test for proportional odds assumption showed that this assumption was satisfied). In this model, baseline 2 h PG and WHR were selected as significant predictors. The odds ratio per unit increase of WHR (unit of WHR ¼ WHRÂ100; values being 0 -100) was 1.05 (95% CI 1.02 -1.07; P ¼ 0.0003) while that per unit increase of 2 h PG was 2.02 (95%CI 1.76 -2.34; P < 0.0001). The variance inflation factors were below 2.0, showing that multicollinearity was not of concern for the variables tested.
Waist circumference and WHR were highly correlated with each other (r ¼ 0.80; P < 0.001). BMI was more highly correlated with waist circumference (r ¼ 0.76, P < 0.001) than with WHR (r ¼ 0.39, P < 0.001). Body weight change from baseline had no impact on glycemic status at 2 y (with BMI increase, NGT 72.8%, IGT 22.6%, DM 4.5%, vs no increase in BMI, NGT 70.1%, IGT 23.7%; DM 6.2%; P ¼ 0.60)
Discussion
This prospective study has demonstrated a high risk of progression to type 2 diabetes in Chinese with IGT, and has identified baseline central obesity and post-load 2 h PG levels as risk factors associated with the high rate of progression. The conversion rate was 9.6% over 2 y or 4.8% per year, compared to only 0.6% per year for NGT subjects. Our progression rate to diabetes is lower than that reported among Chinese living in Kinmen (8.8% per year among IGT; 2.3% per year among NGT). 13 This conversion rate is even lower when compared with those reported from Northern Mainland Chinese in the Da Qing IGT and Diabetes Study (11.3% per year) 12 and from an earlier study among Hong Kong Chinese (11.5% per year). 19 However, the IGT subjects included in the previous Hong Kong study 19 were smaller in number, recruited over a long period of time, and not equally represented in the two sexes. Furthermore, it was not community-based, with subjects being recruited from hospital referrals, and presumably including more high-risk subjects. This might explain the apparently much higher conversion rate compared to our present study. Score test for proportional odds assumption.
WHR, waist -hip ratio; 2 h PG, 2 h plasma glucose.
Central obesity and impaired glucose tolerance NMS Wat et al
The current study was consistent with previous work in finding PG as a major risk factor of future glucose tolerance, 19 -21 but age was not significant when glucose was included in the model.
It is widely accepted that obesity is causally related to type 2 diabetes. 22, 23 However, in this study BMI, an index of overall obesity, was not found to be a significant risk factor in stepwise polytomous logistic regression analysis including also waist circumference and WHR as variables. Similar findings have been reported in a study on Caucasians with IGT. 24 Although absolute weight gain throughout adulthood is an independent risk factor for diabetes in Caucasians, 25 the negative finding in our study cannot exclude its importance among Chinese as the duration of follow-up of 2 y might not be long enough.
When considering obesity as a metabolic risk factor, one needs to take into account the pattern of distribution of body fat. 23 Several prospective studies in non-Chinese populations demonstrated that WHR, a simple anthropometric index of fat distribution, is a strong and independent risk factor for the occurrence of type 2 diabetes, in both men 23, 26 and women. 27 It has been noted that South Asians have a tendency to accumulate intra-abdominal fat without necessarily developing generalized obesity. 28 This tendency was shown to be associated with a higher prevalence of the insulin resistance syndrome when compared to Europeans. 28, 29 In both South Asians and Europeans, glucose intolerance (diabetes and IGT) was more strongly associated with WHR than BMI. 29 Thus, although Southern Asian men were no more overweight than European men, their greater mean WHR was accompanied by a four-fold increase in diabetes prevalence. 28 It has been observed that visceral adipocytes, when compared to subcutaneous adipocytes, are more sensitive to catecholamine-induced lipolysis and less sensitive to the antilipolytic effect of insulin. 30 The greater increase in free fatty acid would lead to greater insulin resistance, both peripheral and hepatic. Although there have been no similar epidemiological data looking at the relationship between abdominal obesity, insulin resistance and glucose tolerance among Chinese as compared to Caucasians, a higher local prevalence of abdominal obesity might explain the apparent discrepancy between the lower prevalence of obesity reflected by BMI among the Chinese population in Hong Kong, but a higher than expected prevalence of type 2 diabetes.
Although the contribution of abdominal obesity to the risk of type 2 diabetes is partly due to its association with insulin resistance, HOMA IR, a simple index of insulin resistance, was not found to be a significant predictor of diabetes in this study. This might be explained by the fact that HOMA IR is only a crude estimate of insulin resistance. Moreover, the importance of insulin resistance in the development of type 2 diabetes might require longer-term followup for clear demonstration.
Estimates of obesity (including BMI, WHR and waist circumference) have been shown to be positively associated with type 2 diabetes incidence in a number of prospective studies involving non-Chinese subjects with IGT. 31 To our knowledge, however, this is the first report of WHR as a significant independent risk factor for the progression to diabetes in IGT subjects among Chinese.
Waist circumference reflects not only intra-abdominal but also subcutaneous fat depots. Besides, waist circumference has also been reported previously to be a strong predictor for type 2 diabetes among Mexican Americans. 32 In this study, although we have not shown that waist circumference, an alternative measurement of central obesity, was superior to WHR or BMI as an independent risk factor for diabetes conversion at 2 y, the ease of its assessment would render it a useful option for identifying people at a higher risk of diabetes. On the other hand, the challenge of achieving successful treatment of obesity lies not in targeting abdominal fat independently of overall fat, but how to convince obese people to make sustainable behavior changes in diet and physical activity in order to reduce body fat as a whole.
In conclusion, among Hong Kong Chinese with IGT, the conversion rate to type 2 diabetes at 2 y was 8-fold that of sex-and age-matched NGT controls. WHR, an index of abdominal obesity, was demonstrated prospectively to be an independent risk factor for the development of type 2 diabetes, in addition to 2-h PG. Abdominal obesity, a highly modifiable risk factor, readily assessed by measurements of WHR or waist circumference, was shown to be associated with the deterioration of glucose tolerance at 2 y.
